Skip to content

Structure and Function of Salivary Proteins

Structure and Function of Salivary Proteins

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00916682
Enrollment
273
Registered
2009-06-09
Start date
2007-11-01
Completion date
2013-06-05
Last updated
2026-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis

Brief summary

This study seeks to provide point-of-care clinical diagnostic systems for the diagnosis of current disease status using saliva as a sample specimen.

Detailed description

The overall hypothesis of this study is that whole saliva and its components, due to its direct anatomic relation to the airways, provides a window on the composition and nature of the disease-specific response in the bronchial, sinus, and nasal airways. By examining proteins created in saliva, we hope to validate that saliva is an important diagnostic tool for for rapid analysis of respiratory status. We further propose that rapid salivary diagnostics will improve patient care in prevalent respiratory diseases with frequent health care utilization and high morbidity, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF).

Interventions

None listed

Sponsors

Boston Children's Hospital
Lead SponsorOTHER
Tufts University
CollaboratorOTHER
Boston University
CollaboratorOTHER
Boston Medical Center
CollaboratorOTHER
University of North Carolina, Chapel Hill
CollaboratorOTHER
Ahura Scientific, Inc.
CollaboratorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 6 or more years of age * confirmed Cystic Fibrosis

Exclusion criteria

* Pregnant

Design outcomes

Primary

MeasureTime frameDescription
Salivary BiomarkersBaselineBiomarkers of inflammation in saliva

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAhmet Uluer, DO

Boston Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 11, 2026